Janssen Pharmaceutica N.v., Belgium

This study aims to observe how standard treatments for relapsed multiple myeloma work in everyday clinical practice. Researchers will follow 300 patients for two years to track treatment effectiveness, safety, and how patients feel. The study is observational, meaning it watches …